Brought to you by 
Marcadia Biotech gets IP from Indiana University
15 Nov 2006
Executive Summary
Marcadia Biotech (treatments for metabolic disorders) licensed technology and IP from Indiana University to use in developing and marketing drugs for metabolic diseases such as diabetes and obesity.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Marcadia Biotech gets IP from Indiana University
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice